白斑治療薬の世界市場：2022年～2026年

世界の白斑治療薬の市場規模は、2022年～2026年の間に3億4,135万米ドルの増加が見込まれ、予測期間中にCAGRで4.5％の成長が予測されています。

市場は、美容の重要性が高まっていること、急速に成長するOTC医薬品や適応外薬の優位性、需給バランスに繋がる適度な競合環境などによって牽引されています。

当レポートでは、世界の白斑治療薬市場について調査分析し、全体的な分析、市場規模と予測、動向、成長促進要因・課題、さらに約25のベンダーを網羅したベンダー分析を提供しています。

目次

第1章 エグゼクティブサマリー

• 市場概要

第2章 市場情勢

• 市場のエコシステム

第3章 市場規模

• 市場の定義
• 市場セグメント分析
• 市場規模：2021年
• 市場の見通し：2021年～2026年の予測

第4章 ファイブフォース分析

• ファイブフォースの要約
• 買い手の交渉力
• サプライヤーの交渉力
• 新興企業の脅威
• 代替品の脅威
• 競合企業の脅威
• 市況

第5章 市場セグメンテーション：投与経路別

• 市場セグメント
• 比較：投与経路別
• 局所 - 市場規模と予測：2021年～2026年
• 経口 - 市場規模と予測：2021年～2026年
• その他 - 市場規模と予測：2021年～2026年
• 市場機会：投与経路別

第6章 顧客情勢

• 顧客情勢の概要

第7章 地域別情勢

• 地域別セグメンテーション
• 地域別比較
• 北米 - 市場規模と予測：2021年～2026年
• 欧州 - 市場規模と予測：2021年～2026年
• アジア - 市場規模と予測：2021年～2026年
• その他の地域（ROW） - 市場規模と予測：2021年～2026年
• 米国 - 市場規模と予測：2021年～2026年
• 中国 - 市場規模と予測：2021年～2026年
• ドイツ - 市場規模と予測：2021年～2026年
• カナダ - 市場規模と予測：2021年～2026年
• 英国 - 市場規模と予測：2021年～2026年
• 市場機会：地域情勢別

第8章 促進要因、課題、および動向

• 市場促進要因
• 市場の課題
• 促進要因と課題の影響
• 市場動向

第9章 ベンダー情勢

• 概要
• ベンダー情勢
• 混乱の状況
• 業界のリスク

第10章 ベンダー分析

• 対象ベンダー
• ベンダーの市場ポジショニング
• Alkem Laboratories Ltd.
• Astellas Pharma Inc.
• Bausch Health Companies Inc.
• Baxter International Inc.
• La Pristine Bioceuticals Pvt. Ltd.
• Mallinckrodt Plc
• Pfizer Inc.
• Puneet Laboratories Pvt. Ltd.
• Teva Pharmaceutical Industries Ltd.
• Viatris Inc.

第11章 付録

Exhibits:

• Exhibits1: Executive Summary - Chart on Market Overview
• Exhibits2: Executive Summary - Data Table on Market Overview
• Exhibits3: Executive Summary - Chart on Global Market Characteristics
• Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
• Exhibits5: Executive Summary - Chart on Market Segmentation by Route of Administration
• Exhibits6: Executive Summary - Chart on Incremental Growth
• Exhibits7: Executive Summary - Data Table on Incremental Growth
• Exhibits8: Executive Summary - Chart on Vendor Market Positioning
• Exhibits9: Parent market
• Exhibits10: Market Characteristics
• Exhibits11: Offerings of vendors included in the market definition
• Exhibits12: Market segments
• Exhibits13: Chart on Global - Market size and forecast 2021-2026 ($ million)
• Exhibits14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
• Exhibits15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
• Exhibits16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)
• Exhibits17: Five forces analysis - Comparison between 2021 and 2026
• Exhibits18: Chart on Bargaining power of buyers - Impact of key factors 2021 and 2026
• Exhibits19: Bargaining power of suppliers - Impact of key factors in 2021 and 2026
• Exhibits20: Threat of new entrants - Impact of key factors in 2021 and 2026
• Exhibits21: Threat of substitutes - Impact of key factors in 2021 and 2026
• Exhibits22: Threat of rivalry - Impact of key factors in 2021 and 2026
• Exhibits23: Chart on Market condition - Five forces 2021 and 2026
• Exhibits24: Chart on Route of Administration - Market share 2021-2026 (%)
• Exhibits25: Data Table on Route of Administration - Market share 2021-2026 (%)
• Exhibits26: Chart on Comparison by Route of Administration
• Exhibits27: Data Table on Comparison by Route of Administration
• Exhibits28: Chart on Topical - Market size and forecast 2021-2026 ($ million)
• Exhibits29: Data Table on Topical - Market size and forecast 2021-2026 ($ million)
• Exhibits30: Chart on Topical - Year-over-year growth 2021-2026 (%)
• Exhibits31: Data Table on Topical - Year-over-year growth 2021-2026 (%)
• Exhibits32: Chart on Oral - Market size and forecast 2021-2026 ($ million)
• Exhibits33: Data Table on Oral - Market size and forecast 2021-2026 ($ million)
• Exhibits34: Chart on Oral - Year-over-year growth 2021-2026 (%)
• Exhibits35: Data Table on Oral - Year-over-year growth 2021-2026 (%)
• Exhibits36: Chart on Others - Market size and forecast 2021-2026 ($ million)
• Exhibits37: Data Table on Others - Market size and forecast 2021-2026 ($ million)
• Exhibits38: Chart on Others - Year-over-year growth 2021-2026 (%)
• Exhibits39: Data Table on Others - Year-over-year growth 2021-2026 (%)
• Exhibits40: Market opportunity by Route of Administration ($ million)
• Exhibits41: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• Exhibits42: Chart on Market share By Geographical Landscape 2021-2026 (%)
• Exhibits43: Data Table on Market share By Geographical Landscape 2021-2026 (%)
• Exhibits44: Chart on Geographic comparison
• Exhibits45: Data Table on Geographic comparison
• Exhibits46: Chart on North America - Market size and forecast 2021-2026 ($ million)
• Exhibits47: Data Table on North America - Market size and forecast 2021-2026 ($ million)
• Exhibits48: Chart on North America - Year-over-year growth 2021-2026 (%)
• Exhibits49: Data Table on North America - Year-over-year growth 2021-2026 (%)
• Exhibits50: Chart on Europe - Market size and forecast 2021-2026 ($ million)
• Exhibits51: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
• Exhibits52: Chart on Europe - Year-over-year growth 2021-2026 (%)
• Exhibits53: Data Table on Europe - Year-over-year growth 2021-2026 (%)
• Exhibits54: Chart on Asia - Market size and forecast 2021-2026 ($ million)
• Exhibits55: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
• Exhibits56: Chart on Asia - Year-over-year growth 2021-2026 (%)
• Exhibits57: Data Table on Asia - Year-over-year growth 2021-2026 (%)
• Exhibits58: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
• Exhibits59: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
• Exhibits60: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
• Exhibits61: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
• Exhibits62: Chart on US - Market size and forecast 2021-2026 ($ million)
• Exhibits63: Data Table on US - Market size and forecast 2021-2026 ($ million)
• Exhibits64: Chart on US - Year-over-year growth 2021-2026 (%)
• Exhibits65: Data Table on US - Year-over-year growth 2021-2026 (%)
• Exhibits66: Chart on China - Market size and forecast 2021-2026 ($ million)
• Exhibits67: Data Table on China - Market size and forecast 2021-2026 ($ million)
• Exhibits68: Chart on China - Year-over-year growth 2021-2026 (%)
• Exhibits69: Data Table on China - Year-over-year growth 2021-2026 (%)
• Exhibits70: Chart on Germany - Market size and forecast 2021-2026 ($ million)
• Exhibits71: Data Table on Germany - Market size and forecast 2021-2026 ($ million)
• Exhibits72: Chart on Germany - Year-over-year growth 2021-2026 (%)
• Exhibits73: Data Table on Germany - Year-over-year growth 2021-2026 (%)
• Exhibits74: Chart on Canada - Market size and forecast 2021-2026 ($ million)
• Exhibits75: Data Table on Canada - Market size and forecast 2021-2026 ($ million)
• Exhibits76: Chart on Canada - Year-over-year growth 2021-2026 (%)
• Exhibits77: Data Table on Canada - Year-over-year growth 2021-2026 (%)
• Exhibits78: Chart on UK - Market size and forecast 2021-2026 ($ million)
• Exhibits79: Data Table on UK - Market size and forecast 2021-2026 ($ million)
• Exhibits80: Chart on UK - Year-over-year growth 2021-2026 (%)
• Exhibits81: Data Table on UK - Year-over-year growth 2021-2026 (%)
• Exhibits82: Market opportunity By Geographical Landscape ($ million)
• Exhibits83: Impact of drivers and challenges in 2021 and 2026
• Exhibits84: Overview on Criticality of inputs and Factors of differentiation
• Exhibits85: Overview on factors of disruption
• Exhibits86: Impact of key risks on business
• Exhibits87: Vendors covered
• Exhibits88: Matrix on vendor position and classification
• Exhibits89: Alkem Laboratories Ltd. - Overview
• Exhibits90: Alkem Laboratories Ltd. - Business segments
• Exhibits91: Alkem Laboratories Ltd. - Key news
• Exhibits92: Alkem Laboratories Ltd. - Key offerings
• Exhibits93: Alkem Laboratories Ltd. - Segment focus
• Exhibits94: Astellas Pharma Inc. - Overview
• Exhibits95: Astellas Pharma Inc. - Product / Service
• Exhibits96: Astellas Pharma Inc. - Key news
• Exhibits97: Astellas Pharma Inc. - Key offerings
• Exhibits98: Bausch Health Companies Inc. - Overview
• Exhibits99: Bausch Health Companies Inc. - Business segments
• Exhibits100: Bausch Health Companies Inc. - Key news
• Exhibits101: Bausch Health Companies Inc. - Key offerings
• Exhibits102: Bausch Health Companies Inc. - Segment focus
• Exhibits103: Baxter International Inc. - Overview
• Exhibits104: Baxter International Inc. - Business segments
• Exhibits105: Baxter International Inc. - Key news
• Exhibits106: Baxter International Inc. - Key offerings
• Exhibits107: Baxter International Inc. - Segment focus
• Exhibits108: La Pristine Bioceuticals Pvt. Ltd. - Overview
• Exhibits109: La Pristine Bioceuticals Pvt. Ltd. - Product / Service
• Exhibits110: La Pristine Bioceuticals Pvt. Ltd. - Key offerings
• Exhibits111: Mallinckrodt Plc - Overview
• Exhibits112: Mallinckrodt Plc - Business segments
• Exhibits113: Mallinckrodt Plc - Key news
• Exhibits114: Mallinckrodt Plc - Key offerings
• Exhibits115: Mallinckrodt Plc - Segment focus
• Exhibits116: Pfizer Inc. - Overview
• Exhibits117: Pfizer Inc. - Product / Service
• Exhibits118: Pfizer Inc. - Key news
• Exhibits119: Pfizer Inc. - Key offerings
• Exhibits120: Puneet Laboratories Pvt. Ltd. - Overview
• Exhibits121: Puneet Laboratories Pvt. Ltd. - Product / Service
• Exhibits122: Puneet Laboratories Pvt. Ltd. - Key offerings
• Exhibits123: Teva Pharmaceutical Industries Ltd. - Overview
• Exhibits124: Teva Pharmaceutical Industries Ltd. - Business segments
• Exhibits125: Teva Pharmaceutical Industries Ltd. - Key news
• Exhibits126: Teva Pharmaceutical Industries Ltd. - Key offerings
• Exhibits127: Teva Pharmaceutical Industries Ltd. - Segment focus
• Exhibits128: Viatris Inc. - Overview
• Exhibits129: Viatris Inc. - Business segments
• Exhibits130: Viatris Inc. - Key offerings
• Exhibits131: Viatris Inc. - Segment focus
• Exhibits132: Inclusions checklist
• Exhibits133: Exclusions checklist
• Exhibits134: Currency conversion rates for US$
• Exhibits135: Research methodology
• Exhibits136: Validation techniques employed for market sizing
• Exhibits137: Information sources
• Exhibits138: List of abbreviations

Technavio has been monitoring the vitiligo therapeutics market and it is poised to grow by $ 341.35 mn during 2022-2026, accelerating at a CAGR of 4.5% during the forecast period. Our report on the vitiligo therapeutics market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis of the current global market scenario, the latest trends and drivers, and the overall market environment. The market is driven by the growing importance of aesthetic appeal, the dominance of OTC and off-label drugs providing volume growth, and a moderately competitive environment leading to demand-supply balance.

The vitiligo therapeutics market analysis includes the Route of administration segment and geographic landscape.

Technavio's vitiligo therapeutics market is segmented as below:

By Route of Administration

• Topical
• Oral
• Others

By Geographical Landscape

• North America
• Europe
• Asia
• Rest of World (ROW)

This study identifies the growing disposable income in emerging countries as one of the prime reasons driving the vitiligo therapeutics market growth during the next few years. Also, pipeline boasting first-in-class drugs and the advent of regenerative medicines will lead to sizable demand in the market.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. Our report on the vitiligo therapeutics market covers the following areas:

• Vitiligo Therapeutics market sizing
• Vitiligo Therapeutics market forecast
• Vitiligo Therapeutics market industry analysis

Technavio's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading vitiligo therapeutics market vendors that include Alkem Laboratories Ltd., AmerisourceBergen Corp., Astellas Pharma Inc., Bausch Health Companies Inc., Baxter International Inc., Biocon Ltd., Canixa Life Sciences, Concord Biotech Ltd., Dr. Reddys Laboratories Ltd., Glenmark Pharmaceuticals Ltd., Intas Pharmaceuticals Ltd., La Pristine Bioceuticals Pvt. Ltd., LEO Pharma AS, Mallinckrodt Plc, Panacea Biotec Ltd., Pfizer Inc., Puneet Laboratories Pvt. Ltd., Sandoz International GmbH, Strides Pharma Science Ltd, Teva Pharmaceutical Industries Ltd., Veloxis Pharmaceuticals AS, and Viatris Inc. Also, the vitiligo therapeutics market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. Technavio's market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

Table of Contents

1 Executive Summary

• 1.1 Market overview
• Exhibit 01: Executive Summary - Chart on Market Overview
• Exhibit 02: Executive Summary - Data Table on Market Overview
• Exhibit 03: Executive Summary - Chart on Global Market Characteristics
• Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
• Exhibit 05: Executive Summary - Chart on Market Segmentation by Route of Administration
• Exhibit 06: Executive Summary - Chart on Incremental Growth
• Exhibit 07: Executive Summary - Data Table on Incremental Growth
• Exhibit 08: Executive Summary - Chart on Vendor Market Positioning

2 Market Landscape

• 2.1 Market ecosystem
• Exhibit 09: Parent market
• Exhibit 10: Market Characteristics

3 Market Sizing

• 3.1 Market definition
• Exhibit 11: Offerings of vendors included in the market definition
• 3.2 Market segment analysis
• Exhibit 12: Market segments
• 3.3 Market size 2021
• 3.4 Market outlook: Forecast for 2021-2026
• Exhibit 13: Chart on Global - Market size and forecast 2021-2026 ($ million)
• Exhibit 14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
• Exhibit 15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
• Exhibit 16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)

4 Five Forces Analysis

• 4.1 Five forces summary
• Exhibit 17: Five forces analysis - Comparison between 2021 and 2026
• 4.2 Bargaining power of buyers
• Exhibit 18: Chart on Bargaining power of buyers - Impact of key factors 2021 and 2026
• 4.3 Bargaining power of suppliers
• Exhibit 19: Bargaining power of suppliers - Impact of key factors in 2021 and 2026
• 4.4 Threat of new entrants
• Exhibit 20: Threat of new entrants - Impact of key factors in 2021 and 2026
• 4.5 Threat of substitutes
• Exhibit 21: Threat of substitutes - Impact of key factors in 2021 and 2026
• 4.6 Threat of rivalry
• Exhibit 22: Threat of rivalry - Impact of key factors in 2021 and 2026
• 4.7 Market condition
• Exhibit 23: Chart on Market condition - Five forces 2021 and 2026

5 Market Segmentation by Route of Administration

• 5.1 Market segments
• Exhibit 24: Chart on Route of Administration - Market share 2021-2026 (%)
• Exhibit 25: Data Table on Route of Administration - Market share 2021-2026 (%)
• 5.2 Comparison by Route of Administration
• Exhibit 26: Chart on Comparison by Route of Administration
• Exhibit 27: Data Table on Comparison by Route of Administration
• 5.3 Topical - Market size and forecast 2021-2026
• Exhibit 28: Chart on Topical - Market size and forecast 2021-2026 ($ million)
• Exhibit 29: Data Table on Topical - Market size and forecast 2021-2026 ($ million)
• Exhibit 30: Chart on Topical - Year-over-year growth 2021-2026 (%)
• Exhibit 31: Data Table on Topical - Year-over-year growth 2021-2026 (%)
• 5.4 Oral - Market size and forecast 2021-2026
• Exhibit 32: Chart on Oral - Market size and forecast 2021-2026 ($ million)
• Exhibit 33: Data Table on Oral - Market size and forecast 2021-2026 ($ million)
• Exhibit 34: Chart on Oral - Year-over-year growth 2021-2026 (%)
• Exhibit 35: Data Table on Oral - Year-over-year growth 2021-2026 (%)
• 5.5 Others - Market size and forecast 2021-2026
• Exhibit 36: Chart on Others - Market size and forecast 2021-2026 ($ million)
• Exhibit 37: Data Table on Others - Market size and forecast 2021-2026 ($ million)
• Exhibit 38: Chart on Others - Year-over-year growth 2021-2026 (%)
• Exhibit 39: Data Table on Others - Year-over-year growth 2021-2026 (%)
• 5.6 Market opportunity by Route of Administration
• Exhibit 40: Market opportunity by Route of Administration ($ million)

6 Customer Landscape

• 6.1 Customer landscape overview
• Exhibit 41: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

7 Geographic Landscape

• 7.1 Geographic segmentation
• Exhibit 42: Chart on Market share By Geographical Landscape 2021-2026 (%)
• Exhibit 43: Data Table on Market share By Geographical Landscape 2021-2026 (%)
• 7.2 Geographic comparison
• Exhibit 44: Chart on Geographic comparison
• Exhibit 45: Data Table on Geographic comparison
• 7.3 North America - Market size and forecast 2021-2026
• Exhibit 46: Chart on North America - Market size and forecast 2021-2026 ($ million)
• Exhibit 47: Data Table on North America - Market size and forecast 2021-2026 ($ million)
• Exhibit 48: Chart on North America - Year-over-year growth 2021-2026 (%)
• Exhibit 49: Data Table on North America - Year-over-year growth 2021-2026 (%)
• 7.4 Europe - Market size and forecast 2021-2026
• Exhibit 50: Chart on Europe - Market size and forecast 2021-2026 ($ million)
• Exhibit 51: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
• Exhibit 52: Chart on Europe - Year-over-year growth 2021-2026 (%)
• Exhibit 53: Data Table on Europe - Year-over-year growth 2021-2026 (%)
• 7.5 Asia - Market size and forecast 2021-2026
• Exhibit 54: Chart on Asia - Market size and forecast 2021-2026 ($ million)
• Exhibit 55: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
• Exhibit 56: Chart on Asia - Year-over-year growth 2021-2026 (%)
• Exhibit 57: Data Table on Asia - Year-over-year growth 2021-2026 (%)
• 7.6 Rest of World (ROW) - Market size and forecast 2021-2026
• Exhibit 58: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
• Exhibit 59: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
• Exhibit 60: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
• Exhibit 61: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
• 7.7 US - Market size and forecast 2021-2026
• Exhibit 62: Chart on US - Market size and forecast 2021-2026 ($ million)
• Exhibit 63: Data Table on US - Market size and forecast 2021-2026 ($ million)
• Exhibit 64: Chart on US - Year-over-year growth 2021-2026 (%)
• Exhibit 65: Data Table on US - Year-over-year growth 2021-2026 (%)
• 7.8 China - Market size and forecast 2021-2026
• Exhibit 66: Chart on China - Market size and forecast 2021-2026 ($ million)
• Exhibit 67: Data Table on China - Market size and forecast 2021-2026 ($ million)
• Exhibit 68: Chart on China - Year-over-year growth 2021-2026 (%)
• Exhibit 69: Data Table on China - Year-over-year growth 2021-2026 (%)
• 7.9 Germany - Market size and forecast 2021-2026
• Exhibit 70: Chart on Germany - Market size and forecast 2021-2026 ($ million)
• Exhibit 71: Data Table on Germany - Market size and forecast 2021-2026 ($ million)
• Exhibit 72: Chart on Germany - Year-over-year growth 2021-2026 (%)
• Exhibit 73: Data Table on Germany - Year-over-year growth 2021-2026 (%)
• 7.10 Canada - Market size and forecast 2021-2026
• Exhibit 74: Chart on Canada - Market size and forecast 2021-2026 ($ million)
• Exhibit 75: Data Table on Canada - Market size and forecast 2021-2026 ($ million)
• Exhibit 76: Chart on Canada - Year-over-year growth 2021-2026 (%)
• Exhibit 77: Data Table on Canada - Year-over-year growth 2021-2026 (%)
• 7.11 UK - Market size and forecast 2021-2026
• Exhibit 78: Chart on UK - Market size and forecast 2021-2026 ($ million)
• Exhibit 79: Data Table on UK - Market size and forecast 2021-2026 ($ million)
• Exhibit 80: Chart on UK - Year-over-year growth 2021-2026 (%)
• Exhibit 81: Data Table on UK - Year-over-year growth 2021-2026 (%)
• 7.12 Market opportunity By Geographical Landscape
• Exhibit 82: Market opportunity By Geographical Landscape ($ million)

8 Drivers, Challenges, and Trends

• 8.1 Market drivers
• 8.2 Market challenges
• 8.3 Impact of drivers and challenges
• Exhibit 83: Impact of drivers and challenges in 2021 and 2026
• 8.4 Market trends

9 Vendor Landscape

• 9.1 Overview
• 9.2 Vendor landscape
• Exhibit 84: Overview on Criticality of inputs and Factors of differentiation
• 9.3 Landscape disruption
• Exhibit 85: Overview on factors of disruption
• 9.4 Industry risks
• Exhibit 86: Impact of key risks on business

10 Vendor Analysis

• 10.1 Vendors covered
• Exhibit 87: Vendors covered
• 10.2 Market positioning of vendors
• Exhibit 88: Matrix on vendor position and classification
• 10.3 Alkem Laboratories Ltd.
• Exhibit 89: Alkem Laboratories Ltd. - Overview
• Exhibit 90: Alkem Laboratories Ltd. - Business segments
• Exhibit 91: Alkem Laboratories Ltd. - Key news
• Exhibit 92: Alkem Laboratories Ltd. - Key offerings
• Exhibit 93: Alkem Laboratories Ltd. - Segment focus
• 10.4 Astellas Pharma Inc.
• Exhibit 94: Astellas Pharma Inc. - Overview
• Exhibit 95: Astellas Pharma Inc. - Product / Service
• Exhibit 96: Astellas Pharma Inc. - Key news
• Exhibit 97: Astellas Pharma Inc. - Key offerings
• 10.5 Bausch Health Companies Inc.
• Exhibit 98: Bausch Health Companies Inc. - Overview
• Exhibit 99: Bausch Health Companies Inc. - Business segments
• Exhibit 100: Bausch Health Companies Inc. - Key news
• Exhibit 101: Bausch Health Companies Inc. - Key offerings
• Exhibit 102: Bausch Health Companies Inc. - Segment focus
• 10.6 Baxter International Inc.
• Exhibit 103: Baxter International Inc. - Overview
• Exhibit 104: Baxter International Inc. - Business segments
• Exhibit 105: Baxter International Inc. - Key news
• Exhibit 106: Baxter International Inc. - Key offerings
• Exhibit 107: Baxter International Inc. - Segment focus
• 10.7 La Pristine Bioceuticals Pvt. Ltd.
• Exhibit 108: La Pristine Bioceuticals Pvt. Ltd. - Overview
• Exhibit 109: La Pristine Bioceuticals Pvt. Ltd. - Product / Service
• Exhibit 110: La Pristine Bioceuticals Pvt. Ltd. - Key offerings
• 10.8 Mallinckrodt Plc
• Exhibit 111: Mallinckrodt Plc - Overview
• Exhibit 112: Mallinckrodt Plc - Business segments
• Exhibit 113: Mallinckrodt Plc - Key news
• Exhibit 114: Mallinckrodt Plc - Key offerings
• Exhibit 115: Mallinckrodt Plc - Segment focus
• 10.9 Pfizer Inc.
• Exhibit 116: Pfizer Inc. - Overview
• Exhibit 117: Pfizer Inc. - Product / Service
• Exhibit 118: Pfizer Inc. - Key news
• Exhibit 119: Pfizer Inc. - Key offerings
• 10.10 Puneet Laboratories Pvt. Ltd.
• Exhibit 120: Puneet Laboratories Pvt. Ltd. - Overview
• Exhibit 121: Puneet Laboratories Pvt. Ltd. - Product / Service
• Exhibit 122: Puneet Laboratories Pvt. Ltd. - Key offerings
• 10.11 Teva Pharmaceutical Industries Ltd.
• Exhibit 123: Teva Pharmaceutical Industries Ltd. - Overview
• Exhibit 124: Teva Pharmaceutical Industries Ltd. - Business segments
• Exhibit 125: Teva Pharmaceutical Industries Ltd. - Key news
• Exhibit 126: Teva Pharmaceutical Industries Ltd. - Key offerings
• Exhibit 127: Teva Pharmaceutical Industries Ltd. - Segment focus
• 10.12 Viatris Inc.
• Exhibit 128: Viatris Inc. - Overview
• Exhibit 129: Viatris Inc. - Business segments
• Exhibit 130: Viatris Inc. - Key offerings
• Exhibit 131: Viatris Inc. - Segment focus

11 Appendix

• 11.1 Scope of the report
• 11.2 Inclusions and exclusions checklist
• Exhibit 132: Inclusions checklist
• Exhibit 133: Exclusions checklist
• 11.3 Currency conversion rates for US$
• Exhibit 134: Currency conversion rates for US$
• 11.4 Research methodology
• Exhibit 135: Research methodology
• Exhibit 136: Validation techniques employed for market sizing
• Exhibit 137: Information sources
• 11.5 List of abbreviations
• Exhibit 138: List of abbreviations